Head of Patient-Facing Quality Assurance

The Role

Every clinical trial depends on a commitment to the people who take part: their rights, safety and wellbeing come first, and the data they help generate can be trusted. Once a product reaches patients, that commitment continues through the monitoring of its safety and benefit-risk. This role holds the organisation to both. As Head of Patient-Facing Quality Assurance, you will lead an integrated QA organisation covering Good Clinical Practice and Good Pharmacovigilance Practice, reporting to the Head of Global R&D Quality. Your team will include PV System and Process Leads, Therapeutic Area Quality Leads, and a Head of Clinical QA or of PV and Regulatory QA, depending on which complements your own background.

Hybrid (3 days a week on site), based in Maidenhead, UK, or King of Prussia, PA, with other global locations open to discussion

Why it matters

Bringing clinical and pharmacovigilance quality under one leader is a deliberate choice. Some of the most consequential risks sit at the interfaces between them: serious adverse event reconciliation, expedited reporting, and the safety information that reaches investigators and regulators. A single function can see these clearly and act on them. The role is also a chance to shape how quality is done, not just police it. With ICH E6(R3) moving the industry toward Quality by Design and risk-based quality management, you will set the strate...